Rybelsus Commercial 2025. Novo nordisk’s first dtc ad for rybelsus shows an animated world that looks a lot better than the real one currently does. Despite pandemic headwinds at launch, novo nordisk’s oral semaglutide med rybelsus has come into its own.
Novo nordisk plans to submit applications for regulatory approval of a label expansion for rybelsus® in both the us and eu around the end of the year, with detailed trial. Novo nordisk’s first dtc ad for rybelsus shows an animated world that looks a lot better than the real one currently does.